INS and obesity disorder: It has been proposed that short-term exposure of β-cells to free fatty acids (FFA) increases glucose-stimulated insulin secretion, while obesity-associated chronic exposure to high FFA levels promotes β-cell hypertrophy and insulin hypersecretion, ultimately causing β-cell dysfunction and death (10–14).